FDA allows marketing of first medical device to prevent migraine headaches

FDA allows marketing of first medical device to prevent migraine headaches

Today, the U.S. Food and Drug Administration allowed marketing of the first device as a preventative treatment for migraine headaches. This is also the first transcutaneous electrical nerve stimulation (TENS) device specifically authorized for use

2
Like
Save

Comments

Write a comment

*